Le Lézard
Classified in: Health
Subject: HEALTH

Making ALS a priority, today and tomorrow


TORONTO, June 01, 2023 (GLOBE NEWSWIRE) -- Today the ALS Society of Canada (ALS Canada) recognizes the start of ALS Awareness Month across the country. Join us as we raise awareness for amyotrophic lateral sclerosis (ALS), a devastating disease that affects more than 3,000 Canadians currently diagnosed and their families.

"ALS is a relentless disease. As we've seen over the past year with the loss of hockey legend Börje Salming and the news of celebrities like Roberta Flack coming forward with her diagnosis, the spotlight has increasingly been on ALS. Still, there is much more to be done," says Tammy Moore, CEO, ALS Canada. "Each year, more people are diagnosed, and each year we lose more of our loved ones. At ALS Canada, we strive to empower people living with ALS to navigate the current realities of the disease, be informed consumers of ALS information, and advocate effectively for change. We invest in the high-quality research that will fuel scientific discovery and hopefully lead to more approved therapies and improved quality of life."

ALS is a neuromuscular disease that paralyzes people because the brain can no longer communicate with the muscles of the body that we are typically able to move at will. As a result, people with ALS face a progressive and devastatingly swift decline in the ability to talk, walk, eat, swallow, and eventually breathe. There is currently no cure for the disease that carries a lifetime risk of 1 in 300 for each of us. ALS Canada works to provide hope for people affected through our investment in research, advocacy, information and community-based services, including direct support provided by the ALS Canada Equipment Program and ALS Canada Community Leads to Ontario families living with ALS.

This June, help us recognize ALS Awareness Month by getting involved with ALS Canada in a variety of ways:

About ALS and the ALS Society of Canada
Amyotrophic lateral sclerosis (ALS) is an unrelenting and currently terminal disease. It progressively paralyzes people because the brain is no longer able to communicate with the muscles of the body that we are typically able to move at will. Over time, as the muscles of the body break down, someone living with ALS will lose the ability to walk, talk, eat, swallow, and eventually breathe. More than 3,000 Canadians live with ALS and approximately 1,000 Canadians are diagnosed each year. Four out of five people living with ALS will die within two to five years of their diagnosis.

The ALS Society of Canada is working to change what it means to live with ALS. Grounded in and informed by the Canadian ALS community, we respond to the urgent unmet need for life-changing treatments by investing in high-quality research that will fuel scientific discovery and by engaging industry, supporting increased clinical capacity and advocating for equitable, affordable, and timely access to proven therapies.

Responding to the tremendous need for current and credible ALS knowledge, awareness and education, we empower Canadians affected by ALS to navigate the current realities of ALS, be informed consumers of ALS information, and advocate effectively for change. In Ontario, we provide direct community services to help people navigate ALS.

Founded in 1977, we are a registered charity that receives no core government funding ? our work is powered by generous donors who share our vision of a future without ALS.

Join the conversation and connect with the ALS community online. Find ALS Canada on Twitter, Instagram, or like our page on Facebook.

For more information
ALS Society of Canada
[email protected]
437-703-5440

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/e8c0014f-9882-4232-ba40-c0d356b3a3b3



These press releases may also interest you

at 11:15
"I wanted to create a natural solution to healing pain and wounds. My design is cost effective and offers a safer alternative to using products with numbing agents or chemicals and addictive ingredients," said an inventor, from Tampa, Fla. "The Pain...

at 11:05
A recent study published in Nature used artificial intelligence to analyze how chemicals from vape flavours transform and affect the human body when heated. This study has received widespread media attention, but its conclusions are flawed and...

at 11:00
Oak...

at 10:51
DefineMe, the women-owned fragrance brand, is thrilled to announce the launch of a transformative addition to its Crystal...

at 10:36
Omega Laboratories, a leading drug testing laboratory renowned for its comprehensive services, proudly announces its strategic partnership with Cannabix Technologies Inc., a pioneer in cannabis breathalyzer technology. This partnership establishes...

at 10:30
3D Bioprinting Market in terms of revenue was estimated to be worth $1.3 billion in 2024 and is poised to reach $2.4 billion by 2029, growing at a CAGR of 12.7% from 2024 to 2029 according to a new report by MarketsandMarketstm. The growth in the 3D...



News published on and distributed by: